Genotype-dependent responses to HIPV exposure in citrus: repression of CsPUB21 and activation of SA/JA signaling

柑橘对HIPV暴露的基因型依赖性反应:CsPUB21的抑制和SA/JA信号的激活

阅读:2

Abstract

Herbivore-induced plant volatiles (HIPVs) are known to activate immune signaling in plants; however, their effectiveness can vary depending on the genotype and the signaling pathway involved. In this study, we evaluated the transcriptional response of four citrus rootstocks (Carrizo citrange, Forner-Alcaide 5 (FA5), Forner-Alcaide 74 (FA74), and Microcitrus australasica) to six synthetic HIPVs [(Z)-3-hexen-1-ol, (Z)-3-hexenyl acetate, (Z)-3-hexenyl butyrate, (Z)-3-hexenyl propanoate, methyl jasmonate, and methyl salicylate]. We focused on genes associated with the salicylic acid (SA) and jasmonic acid (JA) pathways, as well as the susceptibility gene CsPUB21. Overall, the SA pathway was more consistently activated than the JA pathway, with upstream and intermediate genes induced across most genotypes and treatments. In contrast, downstream markers showed more variable expression, suggesting that synthetic HIPVs may induce a primed rather than fully activated defense state. Among the volatiles tested, (Z)-3-hexenyl propanoate and (Z)-3-hexen-1-ol were the most effective, activating genes in both pathways. Importantly, these two compounds also consistently repressed CsPUB21 expression, a gene recently associated with huanglongbing (HLB) susceptibility, through coordinated transcriptional and post-translational regulation. Carrizo citrange showed the strongest transcriptional response, while FA74 exhibited more moderate activation, emphasizing the influence of genetic background on HIPV perception and signaling. These findings highlight the potential of selected synthetic HIPVs as sustainable defense priming agents capable of enhancing citrus immunity by simultaneously activating immune pathways and repressing susceptibility genes such as CsPUB21. This dual mode of action offers promising tools for the integrated management of HLB and other citrus diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。